Study suggests exercise-based cardiac rehab added to stroke recovery improved strength, cardiac endurance ANI | Updated: Jan 31, 2021 15:36 IST
Dallas [US], January 31 (ANI): While exercising regularly has many health benefits, a new study suggested that stroke survivors who completed a cardiac rehabilitation program focused on aerobic exercise significantly improved their ability to transition from sitting to standing, and how far they could walk during a six-minute walking test.
The research was published today in the Journal of the American Heart Association , an open-access journal of the American Heart Association.
Cardiac rehabilitation is a structured exercise program prevalent in the U.S. for people with cardiovascular disease that has been shown to increase cardiovascular endurance and improve quality of life. Despite many similar cardiovascular risk factors, stroke is not among the covered diagnoses for cardiac rehab.
While exercising regularly has many health benefits, a new study suggested that stroke survivors who completed a cardiac rehabilitation program focused on aerobic exercise significantly improved their ability to transition from sitting to standing, and how far they could walk during a six-minute walking test. The research was published today in the Journal of the American Heart Association , an open-access journal of the American Heart Association. Cardiac rehabilitation is a structured exercise program prevalent in the U.S. for people with cardiovascular disease that has been shown to increase cardiovascular endurance and improve quality of life. Despite many similar cardiovascular risk factors, stroke is not among the covered diagnoses for cardiac rehab.
Study on improved strength, cardiac endurance texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Augusta Chronicle
Dr. Gaston Kapuku watched the blood drain from the nurse s face as she sat across from him looking at the machine measuring his blood pressure. I saw her getting pale, almost shaking and asked her why, he said. She said, I don’t believe the number I am reading. Let me check it again.
The young cardiologist, who had just left the catheter lab with a throbbing headache, had blood pressure of 220/140. Anything above 180 and above 120, a patient is considered to be in hypertensive crisis” and should get immediate medical attention, according to the American Heart Association.
JAMA Network Open highlights the lack of price competition in brand-name cardiovascular drugs that significantly impacts patient care.
It confirms what I ve noticed and been infuriated by when prescribing direct oral anticoagulants (DOACs) in clinical practice over the last 10 years.
When the first DOAC Boehringer Ingelheim s dabigatran (Pradaxa) was approved a decade ago, this oral direct thrombin inhibitor became the first new oral anticoagulant approved in the U.S. in more than 50 years. The RE-LY trial showed that 150 mg twice daily lowered the risk of stroke and systemic embolism by 35% beyond the reduction achieved with warfarin, which had been the standard of care for patients with non-valvular atrial fibrillation (afib).